News

Stuart McDougall, Quotient Sciences' Principal Research Fellow of Bioanalytical Services, contributes to the European Bioanalysis Forum Workshop on the Harmonized Implementation of the ICH M10 Guideline.

John McDermott, Vice President of Scientific Consulting at Quotient Sciences, contributes to recent roundtable article with Drug Development & Delivery on 2023 trends.

Dr. Sarah Stevens, Senior Vice President & Head of Early Development & Late-Stage Commercial at Quotient Sciences, recently spoke with Raman Sehgal, host of the Molecule to Market podcast, about her career in the pharmaceutical industry and the differentiated drug development services that Quotient Sciences offers to customers.

Gareth Jenkins, VP Science and Technology, Candidate Development Services at Quotient Sciences, Contributes to Chemistry Today Panel Discussion on Flow Chemistry. Read it here.

Andy Lewis, Vice President, Pharmaceutical Sciences, has written an article for Drug Development & Delivery entitled, "Alternative Strategies for Development of Modified-Release Dosage Forms"

PharmaTech Outlook Interview with Kimberly Paris, SVP & Chief compliance officer at Quotient Sciences: "Addressing and Overcoming the Ever-evolving Challenges in development"